Greenwich LifeSciences, Inc. (GLSI) Earnings History
Net Loss9 years of earnings data (2017–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Greenwich LifeSciences, Inc. (GLSI) Earnings Overview
As of June 28, 2026, Greenwich LifeSciences, Inc. (GLSI) reported trailing twelve-month net income of -$22M, reflecting -18.2% year-over-year growth. The company earned $-1.49 per diluted share over the past four quarters.
Looking at the long-term picture, GLSI's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2017.
Greenwich LifeSciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NKTR (-$158M net income, -297.1% margin), HALO ($349M net income, 22.7% margin), INVA ($504M net income, 63.8% margin), GLSI has comparable earnings metrics. Compare GLSI vs NKTR →
GLSI Earnings vs Peers
Earnings metrics vs comparable public companies
GLSI Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$19M | -11.2% | -$19M | $-1.43 | - | - |
| 2024 | -$17M | -95.8% | -$18M | $-1.21 | - | - |
| 2023 | -$9M | -13.6% | -$9M | $-0.69 | - | - |
| 2022 | -$8M | -71.2% | -$8M | $-0.61 | - | - |
| 2021 | -$5M | -145.4% | -$5M | $-0.35 | - | - |
| 2020 | -$2M | +45.6% | -$2M | $-0.15 | - | - |
| 2019 | -$3M | -102.7% | -$3M | $-0.29 | - | - |
| 2018 | -$2M | -7.4% | -$2M | $-0.14 | - | - |
| 2017 | -$2M | - | -$2M | $-0.13 | - | - |
Download Data
Export GLSI earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GLSI — Frequently Asked Questions
Quick answers to the most common questions about buying GLSI stock.
What is GLSI earnings per share (EPS)?
GLSI trailing twelve-month (TTM) diluted EPS is $-1.49, reflecting -18.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2025 is available in the table on this page.
What is Greenwich LifeSciences, Inc.'s net income?
Greenwich LifeSciences, Inc. (GLSI) trailing twelve-month net income is $-22M as of 2025. Earnings declined -18.2% year-over-year.
Is GLSI profitable?
GLSI is not currently profitable on a TTM basis, reporting a net loss of $-22M. Net margin is N/A. Investors should monitor for a return to profitability.
What is GLSI's earnings growth rate?
GLSI compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2025.
What are GLSI's profit margins?
Greenwich LifeSciences, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -895.3%.
Is GLSI growing earnings?
GLSI earnings are declining — EPS fell -18.2% year-over-year. TTM net income dropped to $-22M. This contrasts with the 5-year CAGR of N/A.
What was GLSI's best earnings year?
Greenwich LifeSciences, Inc.'s highest annual net income on record is $-2M, achieved in fiscal year 2017. Earnings history on this page spans 2017 to 2025 and includes all annual and quarterly figures.
What were GLSI's earnings last quarter?
GLSI's most recent reported quarter was Q1 2026. Net income was $-6M with diluted EPS of $-0.39. For a full breakdown of all quarters, see the quarterly earnings table on this page.